Skip to main content
. 2022 Jan 28;12:721875. doi: 10.3389/fpsyt.2021.721875

Figure 4.

Figure 4

Illustration of quantifying hydroxyzine exposure and calculating prevalence of mental and neuropsychiatric disorders.